| Patent citations as a measure of knowledge flows: The influence of examiner citations J Alcacer, M Gittelman The review of economics and statistics 88 (4), 774-779, 2006 | 946 | 2006 |
| Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns M Gittelman, B Kogut Management Science 49 (4), 366-382, 2003 | 896 | 2003 |
| Applicant and examiner citations in US patents: An overview and analysis J Alcácer, M Gittelman, B Sampat Research Policy 38 (2), 415-427, 2009 | 463 | 2009 |
| Does geography matter for science-based firms? Epistemic communities and the geography of research and patenting in biotechnology M Gittelman Organization science 18 (4), 724-741, 2007 | 337 | 2007 |
| National institutions, public–private knowledge flows, and innovation performance: A comparative study of the biotechnology industry in the US and France M Gittelman Research Policy 35 (7), 1052-1068, 2006 | 161 | 2006 |
| How do I know what you know? Patent examiners and the generation of patent citations J Alcacer, M Gittelman Patent Examiners and the Generation of Patent Citations (August 2004), 2004 | 153 | 2004 |
| A note on the value of patents as indicators of innovation: Implications for management research M Gittelman Academy of Management Perspectives 22 (3), 21-27, 2008 | 143 | 2008 |
| The revolution re-visited: Clinical and genetics research paradigms and the productivity paradox in drug discovery M Gittelman Research Policy 45 (8), 1570-1585, 2016 | 103 | 2016 |
| Research paradigms and useful inventions in medicine: Patents and licensing by teams of clinical and basic scientists in Academic Medical Centers A Ali, M Gittelman Research Policy 45 (8), 1499-1511, 2016 | 50 | 2016 |
| Japanese multinationals in Europe and the United States: some comparisons and contrasts M Gittelman, JH Dunning Multinationals in the new Europe and global trade, 237-268, 1992 | 40 | 1992 |
| Question‐based innovations in strategy research methods A Arora, M Gittelman, S Kaplan, J Lynch, W Mitchell, N Siggelkow Strategic Management Journal 37 (1), 3-9, 2016 | 36 | 2016 |
| How do I know what you know J Alcacer, M Gittelman Patent examiners and the generation of patent citations, 2004 | 36 | 2004 |
| Mapping national knowledge networks: Scientists, firms, and institutions in biotechnology in the United States and France M Gittelman University of Pennsylvania, 2000 | 31 | 2000 |
| What makes research socially useful? Complementarities between in-house research and firm-university collaboration in biotechnology M Gittelman Revue d'économie industrielle 110 (1), 57-73, 2005 | 29 | 2005 |
| The performance and structure of Japanese affiliates in the European Community M Gittelman, E Graham Does ownership matter, 127-158, 1994 | 18 | 1994 |
| Comment: The value of European patents M Gittelman European Management Review 5 (2), 85-89, 2008 | 16 | 2008 |
| Are licensing markets local? An analysis of the geography of vertical licensing agreements in bio-pharmaceuticals J Alcacer, J Cantwell, M Gittelman HBS Working paper, 2009 | 14 | 2009 |
| Scientific maps and innovation: Impact of the human genome on drug discovery S Jayaraj, M Gittelman DRUID Society Conference, 1-56, 2018 | 13 | 2018 |
| Transnational corporations in Europe 1992: implications for developing countries M GITTELMAN The CTC Reporter 29, 35-42, 1990 | 12 | 1990 |
| Japanese multinationals in Europe and the United States: some comparisons and contrasts JH Dunning University of Reading, Department of Economics, 1991 | 11 | 1991 |
Juan AlcacerJames J. Hill Professor of Business AdministrationDirección de correo verificada de hbs.edu
